{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["dysbiosis", "gut microbiota", "herbal medicine", "obesity", "overweight"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37432344", "DateCompleted": {"Year": "2023", "Month": "07", "Day": "13"}, "DateRevised": {"Year": "2023", "Month": "07", "Day": "18"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "05", "Day": "05"}], "Language": ["eng"], "ELocationID": ["2203", "10.3390/nu15092203"], "Journal": {"ISSN": "2072-6643", "JournalIssue": {"Volume": "15", "Issue": "9", "PubDate": {"Year": "2023", "Month": "May", "Day": "05"}}, "Title": "Nutrients", "ISOAbbreviation": "Nutrients"}, "ArticleTitle": "Changes in the Gut Microbiota after the Use of Herbal Medicines in Overweight and Obese Individuals: A Systematic Review.", "Abstract": {"AbstractText": ["Herbal medicine is a low-cost treatment and has been increasingly applied in obesity treatment. Gut microbiota (GM) is strongly associated with obesity pathogenesis.", "We conducted a systematic review guided by the question: \"Does the use of herbal medicine change the GM composition in obese individuals?\" Randomized clinical trials with obese individuals assessing the effects of herbal medicine intervention in GM were retrieved from the Medline, Embase, Scopus, Web of Science, and Cochrane Library databases, including the Cochrane Controlled Trials Register. Two reviewers independently extracted data using standardized piloted data extraction forms and assessed the study-level risk of bias using an Excel template of the Cochrane \"Risk of bias\" tool 2-RoB 2.", "We identified 1094 articles in the databases. After removing duplicates and reading the title and abstract, 14 publications were fully evaluated, of which seven publications from six studies were considered eligible. The herbs analyzed were <i>Moringa oleifera</i>, <i>Punica granatum</i>, <i>Scutellaria baicalensis</i>, <i>Schisandra chinensis</i>, W-LHIT and WCBE. The analysis showed that <i>Schisandra chinensis</i> and <i>Scutellaria baicalensis</i> had significant effects on weight loss herbal intervention therapy composed by five Chinese herbal medicines <i>Ganoderma lucidum</i>, <i>Coptis chinensis</i>, <i>Astragalus membranaceus</i>, <i>Nelumbo nucifera gaertn</i>, and <i>Fructus aurantii</i> (W-LHIT) and white common bean extract (WCBE) on GM, but no significant changes in anthropometry and laboratory biomarkers.", "Herbal medicine modulates GM and is associated with increased genera in obese individuals."]}, "AuthorList": [{"Identifier": ["0000-0001-9166-6606"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Postgraduate Program in Food, Nutrition and Health (PPG-ANS), University of State of Rio de Janeiro, Rio de Janeiro 20550-170, Brazil."}], "LastName": "Huang", "ForeName": "Miguel", "Initials": "M"}, {"Identifier": ["0000-0001-9497-556X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Applied Nutrition, University of State of Rio de Janeiro, Rio de Janeiro 20550-170, Brazil."}], "LastName": "Cople-Rodrigues", "ForeName": "Cl\u00e1udia Dos Santos", "Initials": "CDS"}, {"Identifier": ["0000-0002-9196-9372"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Gastroenterology, Faculdade de Medicina, LIM-35, Hospital das Clinicas HCFMUSP, School of Medicine, Universidade de S\u00e3o Paulo, S\u00e3o Paulo 05508-090, Brazil."}], "LastName": "Waitzberg", "ForeName": "Dan L", "Initials": "DL"}, {"Identifier": ["0000-0003-2945-6872"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Gastroenterology, Faculdade de Medicina, LIM-35, Hospital das Clinicas HCFMUSP, School of Medicine, Universidade de S\u00e3o Paulo, S\u00e3o Paulo 05508-090, Brazil."}], "LastName": "Rocha", "ForeName": "Ilanna Marques Gomes da", "Initials": "IMGD"}, {"Identifier": ["0000-0002-5160-9567"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Nutrition in Public Health, University of State of Rio de Janeiro, Rio de Janeiro 20550-170, Brazil."}], "LastName": "Curioni", "ForeName": "Cintia Chaves", "Initials": "CC"}], "GrantList": [{"GrantID": "process number 26/210.919/2021", "Agency": "Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro", "Country": ""}], "PublicationTypeList": ["Systematic Review", "Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Nutrients", "NlmUniqueID": "101521595", "ISSNLinking": "2072-6643"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Overweight"}, {"QualifierName": [], "DescriptorName": "Gastrointestinal Microbiome"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Obesity"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Plant Extracts"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "GBD 2017 Risk Factor Collaborators Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990\u20132017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1923\u20131994.", "ArticleIdList": ["PMC6227755", "30496105"]}, {"Citation": "Obesity and Overweight. Who.int.  [(accessed on 20 December 2022)].  Available online:  https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight."}, {"Citation": "Astell K.J., Mathai M.L., Su X.Q. Plant extracts with appetite suppressing properties for body weight control: A systematic review of double blind randomized controlled clinical trials. Complement. Ther. Med. 2013;21:407\u2013416. doi: 10.1016/j.ctim.2013.05.007.", "ArticleIdList": ["10.1016/j.ctim.2013.05.007", "23876572"]}, {"Citation": "Apovian C., Aronne L.J., Bessesen D.H., McDonnell M.E., Murad M.H., Pagotto U., Ryan D.H., Still C.D. Pharmacological management of obesity: An endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 2015;100:342\u2013362. doi: 10.1210/jc.2014-3415.", "ArticleIdList": ["10.1210/jc.2014-3415", "25590212"]}, {"Citation": "Mikail H., Mohammed M., Umar H.D., Suleiman M.M. Secondary Metabolites: The Natural Remedies. IntechOpen; London, UK: 2022."}, {"Citation": "Kumar M., Kaushik D., Kaur J., Proestos C., Oz F., Oz E., Gupta P., Kundu P., Kaur A., Anisha A., et al. A critical review on obesity: Herbal approach, bioactive compounds, and their mechanism. Appl. Sci. 2022;12:8342. doi: 10.3390/app12168342.", "ArticleIdList": ["10.3390/app12168342"]}, {"Citation": "Ballini A., Scacco S., Boccellino M., Santacroce L., Arrigoni R. Microbiota and obesity: Where are we now? Biology. 2020;9:415. doi: 10.3390/biology9120415.", "ArticleIdList": ["10.3390/biology9120415", "PMC7761345", "33255588"]}, {"Citation": "Asadi A., Mehr N.S., Mohamadi M.H., Shokri F., Heidary M., Sadeghifard N., Khoshnood S. Obesity and gut-microbiota-brain axis: A narrative review. J. Clin. Lab. Anal. 2022;36:e24420. doi: 10.1002/jcla.24420.", "ArticleIdList": ["10.1002/jcla.24420", "PMC9102524", "35421277"]}, {"Citation": "Yang Q., Liang Q., Balakrishnan B., Belobrajdic D.P., Feng Q.J., Zhang W. Role of dietary nutrients in the modulation of gut microbiota: A narrative review. Nutrients. 2020;12:381. doi: 10.3390/nu12020381.", "ArticleIdList": ["10.3390/nu12020381", "PMC7071260", "32023943"]}, {"Citation": "Feng W., Ao H., Peng C., Yan D. Gut microbiota, a new frontier to understand traditional Chinese medicines. Pharmacol. Res. 2019;142:176\u2013191. doi: 10.1016/j.phrs.2019.02.024.", "ArticleIdList": ["10.1016/j.phrs.2019.02.024", "30818043"]}, {"Citation": "An X., Bao Q., Di S., Zhao Y., Zhao S., Zhang H., Zhang H., Lian F., Tong X. The interaction between the gut microbiota and herbal medicines. Biomed. Pharmacother. 2019;118:109252. doi: 10.1016/j.biopha.2019.109252.", "ArticleIdList": ["10.1016/j.biopha.2019.109252", "31545247"]}, {"Citation": "McGuinness L.A., Higgins J.P.T. Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments. Res. Synth. Methods. 2021;12:55\u201361. doi: 10.1002/jrsm.1411.", "ArticleIdList": ["10.1002/jrsm.1411", "32336025"]}, {"Citation": "Rebello C.J., Burton J., Heiman M., Greenway F.L. Gastrointestinal microbiome modulator improves glucose tolerance in overweight and obese subjects: A randomized controlled pilot trial. J. Diabetes Complicat. 2015;29:1272\u20131276. doi: 10.1016/j.jdiacomp.2015.08.023.", "ArticleIdList": ["10.1016/j.jdiacomp.2015.08.023", "PMC4656110", "26424589"]}, {"Citation": "Cao Z., Wei H., Wen C., Song Y., Srivastava K., Yang N., Shi Y.-M., Miao M., Chung D., Li X.-M. Clinical efficacy of weight loss herbal intervention therapy and lifestyle modifications on obesity and its association with distinct gut microbiome: A randomized double-blind phase 2 study. Front. Endocrinol. 2023;14:1054674. doi: 10.3389/fendo.2023.1054674.", "ArticleIdList": ["10.3389/fendo.2023.1054674", "PMC10073537", "37033234"]}, {"Citation": "Feng Z., Wang Q., Cao H., He F., Guan Y., Li D., Yan J., Yang J., Xia Y., Dong M. White common bean extract remodels the gut microbiota and ameliorates type 2 diabetes and its complications: A randomized double-blinded placebo-controlled trial. Front. Endocrinol. 2022;13:999715. doi: 10.3389/fendo.2022.999715.", "ArticleIdList": ["10.3389/fendo.2022.999715", "PMC9594986", "36303868"]}, {"Citation": "G\u00f3mez-Mart\u00ednez S., D\u00edaz-Prieto L.E., Vicente Castro I., Jurado C., Iturmendi N., Mart\u00edn-Ridaura M.C., Calle N., Due\u00f1as M., Pic\u00f3n M.J., Marcos A., et al. Moringa oleifera leaf supplementation as a glycemic control strategy in subjects with prediabetes. Nutrients. 2021;14:57. doi: 10.3390/nu14010057.", "ArticleIdList": ["10.3390/nu14010057", "PMC8746299", "35010932"]}, {"Citation": "Song M.Y., Wang J.H., Eom T., Kim H. Schisandra chinensis fruit modulates the gut microbiota composition in association with metabolic markers in obese women: A randomized, double-blind placebo-controlled study. Nutr. Res. 2015;35:655\u2013663. doi: 10.1016/j.nutres.2015.05.001.", "ArticleIdList": ["10.1016/j.nutres.2015.05.001", "26048342"]}, {"Citation": "Gonz\u00e1lez-Sarr\u00edas A., Garc\u00eda-Villalba R., Romo-Vaquero M., Alasalvar C., \u00d6rem A., Zafrilla P., Tom\u00e1s-Barber\u00e1n F.A., Selma M.V., Esp\u00edn J.C. Clustering according to urolithin metabotype explains the interindividual variability in the improvement of cardiovascular risk biomarkers in overweight-obese individuals consuming pomegranate: A randomized clinical trial. Mol. Nutr. Food Res. 2017;61:1600830. doi: 10.1002/mnfr.201600830.", "ArticleIdList": ["10.1002/mnfr.201600830", "27879044"]}, {"Citation": "Gonz\u00e1lez-Sarr\u00edas A., Romo-Vaquero M., Garc\u00eda-Villalba R., Cort\u00e9s-Mart\u00edn A., Selma M.V., Esp\u00edn J.C. The endotoxemia marker lipopolysaccharide-binding protein is reduced in overweight-obese subjects consuming pomegranate extract by modulating the gut microbiota: A randomized clinical trial. Mol. Nutr. Food Res. 2018;62:e1800160. doi: 10.1002/mnfr.201800160.", "ArticleIdList": ["10.1002/mnfr.201800160", "29665619"]}, {"Citation": "Shin N.R., Gu N., Choi H.S., Kim H. Combined effects of Scutellaria baicalensis with metformin on glucose tolerance of patients with type 2 diabetes via gut microbiota modulation. Am. J. Physiol. Endocrinol. Metab. 2020;318:E52\u2013E61. doi: 10.1152/ajpendo.00221.2019.", "ArticleIdList": ["10.1152/ajpendo.00221.2019", "31770016"]}, {"Citation": "Deng F., Li Y., Zhao J. The gut microbiome of healthy long-living people. Aging. 2019;11:289\u2013290. doi: 10.18632/aging.101771.", "ArticleIdList": ["10.18632/aging.101771", "PMC6366966", "30648974"]}, {"Citation": "Ahmad A., Yang W., Chen G., Shafiq M., Javed S., Ali Zaidi S.S., Shahid R., Liu C., Bokhari H. Analysis of gut microbiota of obese individuals with type 2 diabetes and healthy individuals. PLoS ONE. 2019;14:e0226372. doi: 10.1371/journal.pone.0226372.", "ArticleIdList": ["10.1371/journal.pone.0226372", "PMC6938335", "31891582"]}, {"Citation": "Vetrani C., Maukonen J., Bozzetto L., Della Pepa G., Vitale M., Costabile G., Riccardi G., Rivellese A.A., Saarela M., Annuzzi G. Diets naturally rich in polyphenols and/or long-chain n-3 polyunsaturated fatty acids differently affect microbiota composition in high-cardiometabolic-risk individuals. Acta Diabetol. 2020;57:853\u2013860. doi: 10.1007/s00592-020-01494-9.", "ArticleIdList": ["10.1007/s00592-020-01494-9", "32114641"]}, {"Citation": "Wan Y., Wang F., Yuan J., Li J., Jiang D., Zhang J., Li H., Wang R., Tang J., Huang T., et al. Effects of dietary fat on gut microbiota and faecal metabolites, and their relationship with cardiometabolic risk factors: A 6-month randomised controlled-feeding trial. Gut. 2019;68:1417\u20131429. doi: 10.1136/gutjnl-2018-317609.", "ArticleIdList": ["10.1136/gutjnl-2018-317609", "30782617"]}, {"Citation": "Castaner O., Goday A., Park Y.M., Lee S.H., Magkos F., Shiow S.A.T.E., Schr\u00f6der H. The gut microbiome profile in obesity: A systematic review. Int. J. Endocrinol. 2018;2018:4095789. doi: 10.1155/2018/4095789.", "ArticleIdList": ["10.1155/2018/4095789", "PMC5933040", "29849617"]}, {"Citation": "Pinart M., D\u00f6tsch A., Schlicht K., Laudes M., Bouwman J., Forslund S.K., Pischon T., Nimptsch K. Gut microbiome composition in obese and non-obese persons: A systematic review and meta-analysis. Nutrients. 2021;14:12. doi: 10.3390/nu14010012.", "ArticleIdList": ["10.3390/nu14010012", "PMC8746372", "35010887"]}, {"Citation": "Fassarella M., Blaak E.E., Penders J., Nauta A., Smidt H., Zoetendal E.G. Gut microbiome stability and resilience: Elucidating the response to perturbations in order to modulate gut health. Gut. 2021;70:595\u2013605. doi: 10.1136/gutjnl-2020-321747.", "ArticleIdList": ["10.1136/gutjnl-2020-321747", "33051190"]}, {"Citation": "Corb Aron R.A., Abid A., Vesa C.M., Nechifor A.C., Behl T., Ghitea T.C., Munteanu M.A., Fratila O., Andronie-Cioara F.L., Toma M.M., et al. Recognizing the benefits of pre-/probiotics in metabolic syndrome and type 2 diabetes mellitus considering the influence of Akkermansia muciniphila as a key gut bacterium. Microorganisms. 2021;9:618. doi: 10.3390/microorganisms9030618.", "ArticleIdList": ["10.3390/microorganisms9030618", "PMC8002498", "33802777"]}, {"Citation": "Adithya K.K., Rajeev R., Selvin J., Seghal Kiran G. Dietary influence on the dynamics of the human gut microbiome: Prospective implications in interventional therapies. ACS Food Sci. Technol. 2021;1:717\u2013736. doi: 10.1021/acsfoodscitech.0c00075.", "ArticleIdList": ["10.1021/acsfoodscitech.0c00075"]}, {"Citation": "Breton J., Galmiche M., D\u00e9chelotte P. Dysbiotic gut bacteria in obesity: An overview of the metabolic mechanisms and therapeutic perspectives of next-generation probiotics. Microorganisms. 2022;10:452. doi: 10.3390/microorganisms10020452.", "ArticleIdList": ["10.3390/microorganisms10020452", "PMC8877435", "35208906"]}, {"Citation": "Maunder A., Bessell E., Lauche R., Adams J., Sainsbury A., Fuller N.R. Effectiveness of herbal medicines for weight loss: A systematic review and meta-analysis of randomized controlled trials. Diabetes Obes. Metab. 2020;22:891\u2013903. doi: 10.1111/dom.13973.", "ArticleIdList": ["10.1111/dom.13973", "31984610"]}, {"Citation": "Whang A., Nagpal R., Yadav H. Bi-directional drug-microbiome interactions of anti-diabetics. EBioMedicine. 2019;39:591\u2013602. doi: 10.1016/j.ebiom.2018.11.046.", "ArticleIdList": ["10.1016/j.ebiom.2018.11.046", "PMC6354569", "30553752"]}, {"Citation": "Lee C.B., Chae S.U., Jo S.J., Jerng U.M., Bae S.K. The relationship between the gut microbiome and metformin as a key for treating type 2 diabetes mellitus. Int. J. Mol. Sci. 2021;22:3566. doi: 10.3390/ijms22073566.", "ArticleIdList": ["10.3390/ijms22073566", "PMC8037857", "33808194"]}, {"Citation": "Choo J.M., Leong L.E.X., Rogers G.B. Sample storage conditions significantly influence faecal microbiome profiles. Sci. Rep. 2015;5:16350. doi: 10.1038/srep16350.", "ArticleIdList": ["10.1038/srep16350", "PMC4648095", "26572876"]}, {"Citation": "Plauzolles A., Toumi E., Bonnet M., P\u00e9naranda G., Bidaut G., Chiche L., Allardet-Servent J., Retornaz F., Goutorbe B., Halfon P. Human stool preservation impacts taxonomic profiles in 16S metagenomics studies. Front. Cell. Infect. Microbiol. 2022;12:722886. doi: 10.3389/fcimb.2022.722886.", "ArticleIdList": ["10.3389/fcimb.2022.722886", "PMC8860989", "35211421"]}, {"Citation": "Scherz V., Greub G., Bertelli C. Building up a clinical microbiota profiling: A quality framework proposal. Crit. Rev. Microbiol. 2022;48:356\u2013375. doi: 10.1080/1040841X.2021.1975642.", "ArticleIdList": ["10.1080/1040841X.2021.1975642", "34752719"]}, {"Citation": "Leeming E.R., Johnson A.J., Spector T.D., Le Roy C.I. Effect of diet on the gut microbiota: Rethinking intervention duration. Nutrients. 2019;11:2862. doi: 10.3390/nu11122862.", "ArticleIdList": ["10.3390/nu11122862", "PMC6950569", "31766592"]}, {"Citation": "Singh N., Stewart R.A.H., Benatar J.R. Intensity and duration of lifestyle interventions for long-term weight loss and association with mortality: A meta-analysis of randomised trials. BMJ Open. 2019;9:e029966. doi: 10.1136/bmjopen-2019-029966.", "ArticleIdList": ["10.1136/bmjopen-2019-029966", "PMC6701694", "31427335"]}, {"Citation": "Klimenko N.S., Tyakht A.V., Popenko A.S., Vasiliev A.S., Altukhov I.A., Ischenko D.S., Shashkova T.I., Efimova D.A., Nikogosov D.A., Osipenko D.A., et al. Microbiome responses to an uncontrolled short-term diet intervention in the frame of the citizen science project. Nutrients. 2018;10:576. doi: 10.3390/nu10050576.", "ArticleIdList": ["10.3390/nu10050576", "PMC5986456", "29738477"]}, {"Citation": "Ehrlich S.D., The MetaHIT Consortium . MetaHIT: The European Union Project on Metagenomics of the Human Intestinal Tract. In: Nelson K.E., editor. Metagenomics of the Human Body. Springer; New York, NY, USA: 2011."}, {"Citation": "Biagini F., Calvigioni M., Lapomarda A., Vecchione A., Magliaro C., De Maria C., Montemurro F., Celandroni F., Mazzantini D., Mattioli-Belmonte M., et al. A novel 3D in vitro model of the human gut microbiota. Sci. Rep. 2020;10:21499. doi: 10.1038/s41598-020-78591-w.", "ArticleIdList": ["10.1038/s41598-020-78591-w", "PMC7725811", "33299026"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "3", "Day": "12"}, {"Year": "2023", "Month": "4", "Day": "28"}, {"Year": "2023", "Month": "5", "Day": "2"}, {"Year": "2023", "Month": "7", "Day": "13", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "7", "Day": "11", "Hour": "13", "Minute": "10"}, {"Year": "2023", "Month": "7", "Day": "11", "Hour": "10", "Minute": "54"}, {"Year": "2023", "Month": "5", "Day": "5"}], "PublicationStatus": "epublish", "ArticleIdList": ["37432344", "PMC10181072", "10.3390/nu15092203", "nu15092203"]}}], "PubmedBookArticle": []}